指南与共识甲状腺疾病

美国甲状腺癌发病率趋势:与专业指南推荐变化的相关性

Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations.
指南 / 共识 · Thyroid · 2020-04-03

研究基于SEER项目最初九个登记处1975至2016年数据,分析甲状腺癌发病率趋势的joinpoint与临床实践指南推荐变化的关系。结果显示甲状腺髓样癌和未分化癌发病率趋势恒定,乳头状甲状腺癌出现三个主要joinpoint,与1996、2009和2015年美国甲状腺协会指南发布及结节活检大小阈值提高等变化在时间上重合。研究提示甲状腺癌发病率趋势在很大程度上但非完全由专业指南推荐变化所塑造。

要点

  • 甲状腺髓样癌和未分化癌发病率趋势在研究期间保持恒定。
  • 乳头状甲状腺癌发病率趋势出现三个主要joinpoint,与1996、2009和2015年ATA指南发布在时间上重合。
  • 非浸润性滤泡性乳头状核特征肿瘤移除「癌」字提案与2015年joinpoint重合,促进总体甲状腺癌发病率下降。

核心结论

  • 本研究提示甲状腺癌发病率趋势在很大程度上但非完全由专业指南推荐变化所塑造。

研究设计与样本

  • 数据来自监测、流行病学和最终结果(SEER)项目最初九个登记处,分析1975年至2016年甲状腺癌发病率。
  • 将甲状腺癌发病率趋势的joinpoint及临床变量与临床实践推荐显著变化进行关联分析。

主要发现

  • 甲状腺髓样癌和未分化甲状腺癌的发病率趋势在研究期间保持恒定。
  • 乳头状甲状腺癌(PTC)中识别出三个主要joinpoint,主要由较小癌症的发病率趋势变化驱动。
  • 甲状腺癌发病率出现加速后两个减速期,分别与1996年、2009年和2015年美国甲状腺协会指南发布在时间上重合。
  • 1996年描述了使用甲状腺超声和细针穿刺活检评估甲状腺结节;2009年和2015年设定了更高的甲状腺结节活检大小阈值。
  • PTC滤泡型在1988年左右出现一个joinpoint,与世界卫生组织分类中该实体组织学诊断的修订重合;2015年另一个joinpoint与提议从非浸润性滤泡性乳头状核特征肿瘤中移除「癌」字重合,该提议有助于拉低总体甲状腺癌发病率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Overdiagnosis is the leading factor contributing to the rapid increase in thyroid cancer incidence of the last decades. During this period, however, thyroid cancer incidence has not been increasing at a constant pace. We hypothesized that changes in the slope of the incidence trends curve, called joinpoints, could be associated with changes in clinical practice guideline recommendations. Methods: Data were obtained from the initial nine registries of the Surveillance, Epidemiology, and End Results (SEER) Program. Thyroid cancer incidence was analyzed from 1975 to 2016. Joinpoints in thyroid cancer incidence trends and clinical variables were correlated with significant changes in clinical practice recommendations. Results: Incidence rate trends of medullary and anaplastic thyroid cancer were constant during the study period. Among papillary thyroid cancers (PTCs), three main joinpoints were identified, mainly driven by changes in incidence trends of smaller cancers. First, acceleration followed by two deceleration periods in thyroid cancer incidence coincident in time with the release of American Thyroid Association guidelines in 1996, 2009, and 2015. In 1996, the use of thyroid ultrasound and fine needle aspiration biopsy for the evaluation of thyroid nodules was described; and in 2009 and 2015, higher size thresholds for the biopsy of thyroid nodules were set. For the follicular variant of PTC, a joinpoint was observed around 1988, when the histological diagnosis of this entity was revised in the World Health Organization classification; and another one in 2015 coinciding with the proposal to remove the term carcinoma from noninvasive follicular-pattern tumors with papillary-like nuclear features which contributed to drive down the overall thyroid cancer incidence. Follicular thyroid cancer incidence was affected as well by changes in the guidelines, but to a lesser extent, and it was fairly stable during the study period. Conclusions: This study suggests that thyroid cancer incidence trends have been shaped, in large part, but not completely, by changes in professional guideline recommendations.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Pereira M, Williams VL, Hallanger Johnson J, et al. Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations. Thyroid. 2020. PMID: 32098591. doi:10.1089/thy.2019.0415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。